Motif Bio Announces New Iclaprim Data being Presented at ECCMID 2018
MOTIF BIO PLC ADRS (MTFB)
US:NASDAQ Investor Relations:
ir.motifbio.com
Company Research
Source: GlobeNewswire
NEW YORK, April 19, 2018 (GLOBE NEWSWIRE) -- Positive efficacy and safety highlights from Phase 3 REVIVE-2 trial in ABSSSIPotential to avoid costs related to vancomycin-associated acute kidney injury in ABSSSIData continue to support iclaprim activity against MRSA and other drug-resistant pathogens Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced that new clinical and pre-clinical data with its investigational drug candidate iclaprim are being presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). Positive efficacy and safety results from REVIVE-2 Phase 3 trial in ABSSSI The REVIVE-2 study was a global Phase 3 trial evaluating iclaprim in patients with acute bacterial skin and skin structure infections (ABSSSI). As previously reported, the study met its primary endpoint of non-inferiority (NI) (10% margin) compared to vancomycin, th
Show less
Read more
Impact Snapshot
Event Time:
MTFB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MTFB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MTFB alerts
High impacting MOTIF BIO PLC ADRS news events
Weekly update
A roundup of the hottest topics